Cytrx Corp - Net Worth and Insider Trading
Cytrx Corp Net Worth
The estimated net worth of Cytrx Corp is at least $4 dollars as of 2024-09-21. Cytrx Corp is the 10% Owner of Phio Pharmaceuticals Corp and owns about 1 shares of Phio Pharmaceuticals Corp (PHIO) stock worth over $4. Cytrx Corp is also the 10% Owner of SELLAS Life Sciences Group Inc and owns about 0 shares of SELLAS Life Sciences Group Inc (SLS) stock worth over $0. Details can be seen in Cytrx Corp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Cytrx Corp has not made any transactions after 2010-12-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Cytrx Corp
Cytrx Corp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Cytrx Corp owns 1 companies in total, including SELLAS Life Sciences Group Inc (SLS) .
Click here to see the complete history of Cytrx Corp’s form 4 insider trades.
Insider Ownership Summary of Cytrx Corp
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SLS | SELLAS Life Sciences Group Inc | 2010-12-29 | 10 percent owner |
Cytrx Corp Latest Holdings Summary
Cytrx Corp currently owns a total of 2 stocks. Among these stocks, Cytrx Corp owns 1 shares of Phio Pharmaceuticals Corp (PHIO) as of February 14, 2008, with a value of $4 and a weighting of 100%. Cytrx Corp also owns 0 shares of SELLAS Life Sciences Group Inc (SLS) as of December 29, 2010, with a value of $0 and a weighting of 0%.
Latest Holdings of Cytrx Corp
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
PHIO | Phio Pharmaceuticals Corp | 2008-02-14 | 1 | 3.54 | 4 |
SLS | SELLAS Life Sciences Group Inc | 2010-12-29 | 0 | 1.21 | 0 |
Holding Weightings of Cytrx Corp
Cytrx Corp Form 4 Trading Tracker
According to the SEC Form 4 filings, Cytrx Corp has made a total of 0 transactions in Phio Pharmaceuticals Corp (PHIO) over the past 5 years. The most-recent trade in Phio Pharmaceuticals Corp is the sale of 0 shares on February 14, 2008, which brought Cytrx Corp around $0.
According to the SEC Form 4 filings, Cytrx Corp has made a total of 0 transactions in SELLAS Life Sciences Group Inc (SLS) over the past 5 years. The most-recent trade in SELLAS Life Sciences Group Inc is the sale of 86 shares on December 29, 2010, which brought Cytrx Corp around $6 Million.
Insider Trading History of Cytrx Corp
- 1
Cytrx Corp Trading Performance
Cytrx Corp Ownership Network
Cytrx Corp Owned Company Details
What does SELLAS Life Sciences Group Inc do?
Who are the key executives at SELLAS Life Sciences Group Inc?
Cytrx Corp is the 10 percent owner of SELLAS Life Sciences Group Inc. Other key executives at SELLAS Life Sciences Group Inc include EVP & Gen. Counsel & Corp. Sec. Barbara A Wood , VP & Finance & Corp Controller John Thomas Burns , and director & President and CEO Angelos M. Stergiou .
SELLAS Life Sciences Group Inc (SLS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of SELLAS Life Sciences Group Inc (SLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of SELLAS Life Sciences Group Inc (SLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
SELLAS Life Sciences Group Inc (SLS)'s detailed insider trading history can be found in Insider Trading Tracker table.
SELLAS Life Sciences Group Inc Insider Transactions
Cytrx Corp Mailing Address
Above is the net worth, insider trading, and ownership report for Cytrx Corp. You might contact Cytrx Corp via mailing address: 11726 San Vicente Boulevard, Suite 650, Los Angeles Ca 90049.